A Novel and Rapid Platform to Generate Gram-level Antibodies for Diagnostic and Therapeutic Use

Combining our rich experience in molecular biology and cell system engineering, GenScript has established the TurboCHO™ High Performance (HP) platform to enable kilogram level production within a short timeframe. We could reach the typical titer for mAbs up to 3.1 g/L and accept a range of purified antibody products (e.g., IgGs, Fab, scFv, VHH, bi-specific antibodies, and more) in quantities. This newly upgraded production could support various applications, including functional, structural, and therapeutic studies. In addition, the high performance projects will rely on the same expression system for the best consistency and minimal surprises during downstream steps, strengthening the flow of drugs into clinical evaluation with an effective mitigation strategy through gram levels of protein and antibody production. In this webinar, we will introduce how GenScript TurboCHO-HP can assist and support in your diagnostic and antibody drug discovery development.

In this webinar, you will learn

The importance of protein expression in antibody drug discovery.

The progress of CHO cell line development.

How GenScript TurboCHO platform provides protein/antibody expression services for antibody drug discovery solutions.

In this webinar, you will learn

Webinar Details

  • Speaker: Hao Tan, Ph.D., Head of Shanghai Cell Line and Virus Vector Development Department, GenScript
  • Date: Tuesday, August 16th, 2022
  • Time: 12:00 PM EDT/ 9:00 AM PDT
  • Support: [email protected]

Related Services & Products

Speaker-related Webinars

Do you like the current new website?